Neural Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is August - July.

Millions CAD. Fiscal year is Aug - Jul.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 14, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Market Capitalization	2	2	-	-	-
Enterprise Value	2	3	-	-	-
Last Close Price	0.01	0.03	-	-	-
PB Ratio	2.58	-3.05	-	-	-
Debt / Equity Ratio	1.23	-1.02	-0.56	-0.53	-
Net Debt / Equity Ratio	1.14	-0.80	-0.46	0.51	39.29
Quick Ratio	0.38	0.98	0.31	0.72	0.91
Current Ratio	0.39	1.10	0.31	0.74	0.98
Return on Assets (ROA)	-50.56%	-422.30%	-183.08%	-186.98%	-
Return on Capital Employed (ROCE)	-61.00%	-5824.00%	311.30%	982.80%	7830.90%
Earnings Yield	-74.97%	-46.27%	-	-	-
Buyback Yield / Dilution	-87.15%	-19.37%	-58.39%	-7.98%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.